Skip to main content
OpenTrials

Clinical trial condition

Dendritic Cell Sarcoma, Interdigitating

Explore clinical trials studying Dendritic Cell Sarcoma, Interdigitating. Study availability and eligibility vary by location and protocol.

236 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Dendritic Cell Sarcoma, Interdigitating trial results

Completed

Quality of Life in Children Treated for Cancer

NCT00005881

Conditions
Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +27 more
Locations
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
View all 17 locations
View Trial Details
Completed

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

NCT00006340

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +47 more
Locations
  • Methodist Cancer Center at Methodist Hospital Indianapolis, Indiana, United States
  • Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Hopital Necker Paris, France
View Trial Details
Completed

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

NCT00002543

Conditions
Brain and Central Nervous System Tumors, Burkitt Lymphoma, Central Nervous System Neoplasms, +33 more
Locations
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Boston Floating Hospital Infants and Children Boston, Massachusetts, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

NCT00994500

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +90 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions